https://www.selleckchem.com/pr....oducts/selonsertib-g
05. There were no differences in blood product volume, hemolysis labs, transfusion reactions, complications, or survival. We then separated patients by Rh status (577 were Rh+, 70 were Rh-). Rh- patients were Rh- were older (median age 54 vs 39), more likely to be female (57 vs 26%), and more likely to have sustained blunt trauma than their Rh + counterparts (92 vs. 70%); all p 0.05. There were no differences in hemolysis labs, transfusion reactions, complications, or survival between Rh + and Rh- patients, regardless o
Aimer
Commentaire
Partagez
